ECSP067030A - Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento - Google Patents

Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento

Info

Publication number: ECSP067030A
Authority: EC; Ecuador
Prior art keywords: clormadinone; ethinylestradiol; acetate; preparation; combination
Prior art date: 2004-05-28

Application number

EC2006007030A

Other languages

English (en)

Inventor

Johannes Bartholomaeus

Janine Klose

Klaus-Michael Wilsmann

Original Assignee

Gruenenthal Chemie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-28

Filing date

2006-11-27

Publication date

2006-12-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34982562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP067030(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-11-27 Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie

2006-12-29 Publication of ECSP067030A publication Critical patent/ECSP067030A/es

Links

BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 title 1
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 title 1
BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 title 1
VUHJZBBCZGVNDZ-TTYLFXKOSA-N chlormadinone Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 VUHJZBBCZGVNDZ-TTYLFXKOSA-N 0.000 title 1
229960002568 ethinylestradiol Drugs 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

EC2006007030A 2004-05-28 2006-11-27 Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento ECSP067030A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE102004026669A DE102004026669A1 (de)	2004-05-28	2004-05-28	Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels

Publications (1)

Publication Number	Publication Date
ECSP067030A true ECSP067030A (es)	2006-12-29

Family

ID=34982562

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EC2006007030A ECSP067030A (es)	2004-05-28	2006-11-27	Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento

Country Status (11)

Country	Link
US (1)	US20050267081A1 (es)
EP (1)	EP1753435A1 (es)
AR (1)	AR049195A1 (es)
AU (1)	AU2005247101B2 (es)
BR (1)	BRPI0511864A (es)
DE (1)	DE102004026669A1 (es)
EC (1)	ECSP067030A (es)
MX (1)	MXPA06013800A (es)
PE (1)	PE20060402A1 (es)
RU (1)	RU2394579C2 (es)
WO (1)	WO2005115402A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102004026671A1 (de) *	2004-05-28	2005-12-15	Grünenthal GmbH	Darreichungsform zur hormonalen Kontrazeption
DE102006003509A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Kontrazeptivum
DE102006003508A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Arzneimittel umfassend eine Hormonkombination
DE102006062119A1 (de) *	2006-12-22	2008-06-26	Grünenthal GmbH	Arzneimittel zur Behandlung von Hauterkrankungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU4805085A (en) *	1984-09-05	1986-03-24	Schering Aktiengesellschaft	Mittel zur behandlung von androgenisierungserscheinungen und verwendung von antiandrogenen zur herstellung des mittels
DE3916112A1 (de) *	1989-05-16	1990-11-22	Schering Ag	Dihydrospirorenon als antiandrogen
DE4104385C1 (es) *	1991-02-09	1992-08-13	Marika Dr.Med. 6509 Framersheim De Ehrlich
US5468736A (en) *	1993-02-25	1995-11-21	The Medical College Of Hampton Road	Hormone replacement therapy
DE19525017A1 (de) *	1995-06-28	1997-01-02	Schering Ag	Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
US6511970B1 (en) *	1996-09-13	2003-01-28	New Life Pharmaceuticals Inc.	Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
DE19739916C2 (de) *	1997-09-11	2001-09-13	Hesch Rolf Dieter	Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US6326392B1 (en) *	1997-11-06	2001-12-04	American Home Products Corporation	Anti-estrogen plus progestin containing oral contraceptives
EP2002839A1 (en) *	1998-04-17	2008-12-17	Ortho McNeil Pharmaceutical, Inc.	Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
US6265393B1 (en) *	1998-08-07	2001-07-24	Heinrichs William Leroy	Prevention of endometriosis signs or symptons
SK9592002A3 (en) *	2000-01-28	2003-12-02	Endorech Inc	A method for reduction or elimination of the incidence of menopausal symptoms, method of treatment or decreasing the risk of an acquiring disease, a pharmaceutical composition and a kit
DE10045380A1 (de) *	2000-09-14	2002-04-04	Schering Ag	Verfahren zur Kontrazeption und dessen Darreichungsform
ES2278924T3 (es) *	2001-05-18	2007-08-16	Pantarhei Bioscience B.V.	Composicion farmaceutica para el uso en terapia de sustitucion hormonal.
CN1674880A (zh) *	2002-08-15	2005-09-28	惠氏公司	用于治疗体温调节机能障碍的5HT2a受体的激动作用
US7772219B2 (en) *	2003-05-02	2010-08-10	Teva Women's Health, Inc.	Methods of hormonal treatment utilizing extended cycle contraceptive regimens

2004
- 2004-05-28 DE DE102004026669A patent/DE102004026669A1/de not_active Withdrawn
- 2004-12-10 US US11/009,361 patent/US20050267081A1/en not_active Abandoned
2005
- 2005-05-27 BR BRPI0511864-6A patent/BRPI0511864A/pt not_active Application Discontinuation
- 2005-05-27 WO PCT/EP2005/005764 patent/WO2005115402A1/de not_active Ceased
- 2005-05-27 AU AU2005247101A patent/AU2005247101B2/en not_active Ceased
- 2005-05-27 RU RU2006145077/15A patent/RU2394579C2/ru active
- 2005-05-27 EP EP05763426A patent/EP1753435A1/de not_active Ceased
- 2005-05-27 AR ARP050102211A patent/AR049195A1/es unknown
- 2005-05-27 PE PE2005000595A patent/PE20060402A1/es not_active Application Discontinuation
- 2005-05-27 MX MXPA06013800A patent/MXPA06013800A/es active IP Right Grant
2006
- 2006-11-27 EC EC2006007030A patent/ECSP067030A/es unknown

Also Published As

Publication number	Publication date
AU2005247101B2 (en)	2011-02-17
RU2394579C2 (ru)	2010-07-20
PE20060402A1 (es)	2006-07-12
BRPI0511864A (pt)	2008-01-22
DE102004026669A1 (de)	2005-12-15
AU2005247101A1 (en)	2005-12-08
EP1753435A1 (de)	2007-02-21
AR049195A1 (es)	2006-07-05
WO2005115402A1 (de)	2005-12-08
RU2006145077A (ru)	2008-07-10
US20050267081A1 (en)	2005-12-01
MXPA06013800A (es)	2007-02-02

Publication	Publication Date	Title
IL183929A0 (en)	2008-12-29	Use of inerferon - ?? in the preparation of a medicament
IL188732A (en)	2014-07-31	Use of ibuprofen and pamotidine for drug preparation
MA28489B1 (fr)	2007-03-01	Preparations pharmaceutiques
EP1789075A4 (en)	2009-07-01	ABSORPTION ENHANCER FOR DRUG ADMINISTRATION
BRPI0811865A2 (pt)	2014-11-18	Derivados heterocíclicos pirrolo-nitrogenados, a preparação e o uso farmacêutico dos mesmos
IL219671A0 (en)	2012-06-28	1,2- benzoxazoles and use thereof in the preparation of a medicament
IL183101A0 (en)	2007-10-31	Use of cannabinoids in the manufacture of medicaments
IL181964A0 (en)	2007-07-04	Medicaments comprising carbonyl compounds, and the use thereof
IL182624A0 (en)	2007-07-24	2-amido-4 phenylthiazole derivatives, the preparation and the therapeutic use thereof
IL184288A0 (en)	2007-10-31	18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
IL180770A0 (en)	2007-06-03	Oxopiperidine derivatives, preparation and therapeutic use thereof
IS7564A (is)	2004-11-29	Lyfjablanda með breytta losun
ZA200705086B (en)	2008-08-27	Catalytic materials and method for the preparation thereof
BRPI0717369A2 (pt)	2014-10-07	Composto, medicamento, composição farmacêutica que o contém e uso do composto.
IL184008A0 (en)	2007-10-31	4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
PL394604A1 (pl)	2011-07-18	Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
CL2008000866A1 (es)	2008-10-03	Uso monofasico de una composicion farmaceutica que comprende 17 beta estradiol y acetato de nomegestrol para la anticoncepcion.
IL190519A0 (en)	2008-11-03	6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
PL1799188T3 (pl)	2015-09-30	Zastosowanie peptydów jako środka antyoksydantowego do otrzymywania kompozycji kosmetycznej i/lub farmaceutycznej
IL182385A0 (en)	2007-07-24	Pyridine derivatives and the preparation and the therapeutic use thereof
EP1757282A4 (en)	2010-02-10	USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
ECSP067030A (es)	2006-12-29	Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento
EP1889622A4 (en)	2009-12-23	SPIROPIPERIDINE COMPOUND AND MEDICINAL USE THEREOF
ATE409463T1 (de)	2008-10-15	Oral dispergierbare pharmazeutische zusammensetzung und verfahren zu ihrer herstellung
IL178311A0 (en)	2007-02-11	Stabilised tat antigen and the use thereof for anti-hiv vaccination